Pain Therapeutics Aktie - PTIE

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

1,24

Gebot

1,19

Fragen

1,28

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

1,24

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.

AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development...

Pain Therapeutics Reports 2018 Financial Results and Corporate Update

AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported...

Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY

AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage...

Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin

AUSTIN, Texas, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development...

Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health

AUSTIN, Texas, Jan. 16, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage...

Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY

AUSTIN, Texas, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a clinical-stage...

Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1

AUSTIN, Texas, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced the...

Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease

AUSTIN, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical...

Pain Therapeutics Appeals FDA Decision on REMOXY

AUSTIN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical...

Pain Therapeutics Reports Third Quarter 2018 Financial Results

- Phase IIa Study Initiation On-track for Q4 2018 - AUSTIN, Texas, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Pain...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

PTIE - Frequently Asked Questions (FAQ)

What is the current Pain Therapeutics share price?

The current share price of Pain Therapeutics is US$ 1,24

What is the 1 year trading range for Pain Therapeutics share price?

Pain Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
BDSXBiodesix Inc	US$ 1,08 (51,47%)	517,27k
PTIXProtagenic Therapeutics Inc	US$ 0,41 (48,39%)	21,59M
LNKSLinkers Industries Ltd	US$ 0,85 (30,77%)	3
GCLGCL Global Holdings Ltd	US$ 2,59 (28,22%)	522
IKTInhibikase Therapeutics Inc	US$ 2,91 (28,19%)	10
SPGCSacks Parente Golf Inc	US$ 0,1092 (-42,53%)	10,34M
SYRESpyre Therapeutics Inc	US$ 11,00 (-38,68%)	4
EVCMEverCommerce Inc	US$ 6,20 (-36,28%)	4
OPCHOption Care Health Inc	US$ 22,01 (-35,19%)	17
EOLSEvolus Inc	US$ 9,32 (-35,01%)	8
SUNESUNation Energy Inc	US$ 0,224 (-6,67%)	45,69M
BTOGBit Origin Ltd	US$ 0,4057 (27,06%)	40,32M
AGMHAGM Group Holdings Inc	US$ 0,139 (4,51%)	22,11M
PTIXProtagenic Therapeutics Inc	US$ 0,4081 (47,70%)	21,6M
SPGCSacks Parente Golf Inc	US$ 0,1092 (-42,53%)	10,34M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pain Therapeutics, Inc. (MM) (PTIE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

PTIE Neueste Nachrichten

Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.

Pain Therapeutics Reports 2018 Financial Results and Corporate Update

Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY

Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin

Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health

Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY

Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1

Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease

Pain Therapeutics Appeals FDA Decision on REMOXY

Pain Therapeutics Reports Third Quarter 2018 Financial Results

PTIE - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pain Therapeutics, Inc. (MM) (PTIE) Börsenkurse

Pain Therapeutics, Inc. (MM) (PTIE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

PTIE Neueste Nachrichten

Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.

Pain Therapeutics Reports 2018 Financial Results and Corporate Update

Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY

Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin

Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health

Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY

Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1

Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease

Pain Therapeutics Appeals FDA Decision on REMOXY

Pain Therapeutics Reports Third Quarter 2018 Financial Results

PTIE - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS